Application Note: Gyrolab immunoassays to support vaccine development and production
22 December 2020
Vaccines are key weapons in the fight against infectious disease and as immunotherapies for other conditions including certain cancers and Alzheimer’s disease. Vaccines must be shown to be safe, pure, potent, and effective for regulatory approval.
In this application note, Gyros Protein Technologies present examples of how Gyrolab® systems have boosted the performance of vaccine R&D, from detecting plasma antibodies in vaccines and determining the affinity of antigen-antibody interactions in early development, to the measurement of antigen titer and HCP impurities in bioprocess.